Catabasis Pharmaceuticals' Series B - II Round

Catabasis Pharmaceuticals raised a round of funding on March 31, 2015.

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's dru…

Articles about Catabasis Pharmaceuticals' Series B - II Round: